Embleema’s leadership team brings together more than 100 years of industry experience in life sciences, healthcare data, wearable, digital health & Blockchain technology across the US, Europe & Asia-Pacific.
Vahan Simonyan, PhD
He has expertise in biotechnology and biomedical informatics, previously serving at the FDA as a lead scientist of HIVE, R&D Director of Bioinformatics. Additionally, Dr. Simonyan is an adjunct professor at the George Washington University, where he teaches and develops curriculums for biomedical big data informatics and biostatistics research and development courses. Vahan is an advisor to several biotech companies and governmental agencies in digital healthcare. Vahan has a solid scientific background in varied academic disciplines: MS in Physical Organic Chemistry, Ph.D. in Quantum Physics and Mathematics, post-doctoral training in Nanotechnology and Quantum Statistical Thermodynamics. He is a prolific author of scientific publications in physics, chemistry, quantum chemistry, nanotechnology, biotechnology, population dynamics, and bioinformatics and a recipient of multiple awards and grants for health informatics and biomedical informatics projects.
Robert is the Co-founder & CEO of Embleema. He is the former SVP of Global Technology for IQVIA & has created & managed data networks in over 20 countries in the U.S., Asia & Europe.
Pascale is a Board Member of Horizon Pharma, Perkin Elmer, Fresenius Medical Care & other companies. Pascale is the former EVP for the Global Diabetes and Cardiovascular franchise for Sanofi.
Pr. Alexander Eggermont
Lex is a globally recognized leader in cancer research & care. He is the former General Director of Gustave Roussy, European’s number one cancer care & research center.
Leena Das-Young, Pharm.D.
Leena is a seasoned C-level Life Sciences executive & advisor. She is the Founder and Principal at RaniBio & the former Head of Late Phase Oncology Development at Pfizer.
Adel is a seasoned global technology executive. He is a global leader in technology services after holding several senior executive positions at IBM Corp & IMS Health.
Bernard Gilly, PhD
Bernard is a serial entrepreneur in Ophthalmology biotechnology, he is the CEO of Gensight & Chairman of iBionext.